Hip News

Published results showed obstructive sleep apnea had a significant association with overall complications, as well as pulmonary and thromboembolic complications, among patients after total joint arthroplasty.

Published results showed patients who underwent revision total hip arthroplasty with a fellowship-trained surgeon had improved outcomes vs. patients who underwent surgery with a non-fellowship-trained surgeon.

Results from a propensity-matched, retrospective cohort study showed periprosthetic joint infection within 1 year after total hip arthroplasty was associated with an almost 5.5 times increased 10-year mortality risk among patients.

Patients with failed spinal anesthesia prior to total hip or knee arthroplasty had inferior clinical outcomes compared with patients who had successful spinal anesthesia and similar outcomes vs. those who received general anesthesia.

Patients who underwent two-stage revision total hip arthroplasty for periprosthetic joint infection had a minimum 2-year infection-free survivorship of 73.8% and improved patient-reported outcomes at midterm to long-term follow-up.

According to published results, flexible pes planovalgus, also known as flatfoot deformity, was associated with increased risks of falls, implant-related complications and revision surgery among patients undergoing total hip arthroplasty.

Published results showed the direct anterior approach for total hip arthroplasty was associated with significantly increased physiological stress and strain for surgeons compared with the posterior approach.

OsteoRemedies LLC announced FDA clearance for expanded indications of its Spectrum GV dual antibiotic bone cement for the use in revision total hip arthroplasty procedures, according to a press release.

Postoperative chemotherapy may be associated with increased risk of periprosthetic joint infection after total joint arthroplasty, according to published results.

According to published results, perioperative IV dexamethasone was associated with decreased risk for pulmonary embolism and deep vein thrombosis after total joint arthroplasty for patients with a history of venous thromboembolism.